Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Platelet-Rich Plasma for Treatment of Peyronie's Disease
NCT04512287Phase 2Completed
- Sponsor
- University of Miami
- Start
- Mar 2021
- Primary completion
- Aug 2025
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
A Phase 2 trial of autologous platelet-rich plasma in Peyronie's disease, sponsored by University of Miami. Started Mar 2021; status: completed.
02
Drugs
autologous platelet-rich plasma
03
Conditions
Peyronie's disease
Beyond the preview
Go deeper on NCT04512287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04512287.